NCT00309322View on ClinicalTrials.gov

Study of NV-101 for Safety and Efficacy in Pediatric Dental Patients Undergoing Procedures

PHASE2CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

March 31, 2006

Study Completion Date

August 31, 2006

Conditions
Anesthesia, Dental
Interventions
DRUG

Phentolamine Mesylate (NV-101)

Trial Locations (1)

02115

The Forsyth Institute, Boston

Sponsors
All Listed Sponsors
lead

Novalar Pharmaceuticals, Inc.

INDUSTRY

NCT00309322 - Study of NV-101 for Safety and Efficacy in Pediatric Dental Patients Undergoing Procedures | Biotech Hunter | Biotech Hunter